AI assistant
Medica Major Shareholding Notification 2022
4116_mrq_2022-03-22_2dbcd663-f2cb-46e7-82a8-0b7e53527162.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
MEDICA S.p.A. Via Degli Artigiani, 7 41036 MEDOLLA MODENA - ITALY
Tel. 0535 51159 Fax 0535 52605 e-mail: [email protected] home page: www.medica.it
International: Tel. +39 0535 51159 Fax +39 0535 52605
Press release
MEDICA S.P.A.
ESTABLISHMENT OF THE HOLDING COMPANY CONTROLLING MEDICA Communication pursuant to art. 17 of the Issuers' Regulations
Medolla (MO), 22 March 2022 – Medica S.p.A., fully integrated Italian biomedical and MedTech group with a strong international footprint, announces that it has received today the communication from Luciano Fecondini and Andrea Bocchi, shareholders of Medica SpA, that they have conferred the total of their shares in Medica, respectively 2.426.670 and 948.930 shares, in the newly established holding company Pelmo87 Srl. Luciano Fecondini and Andrea Bocchi have thus followed up on the commitment signed in the shareholders' agreement of 30 September 2021 to establish a holding company that is controlled by Luciano Fecondini and that is the controlling shareholder of Medica SpA, further strengthening the guarantee of a unitary and stable direction to the company Medica Spa.
Consequently, Pelmo87 Srl holds 3.375.600 ordinary shares equal to 79,93% of the share capital of Medica.
Below is the composition of the corporate structure of Medica SpA and its parent company Pelmo87 Srl, because of the transfer:
| Shareholders of Medica SpA |
Nr Shares | % of share capital with right of vote |
|---|---|---|
| Pelmo87 Srl |
3.375.600 | 79,93% |
| Free Float | 847.650 | 20,07% |
| Total | 4.223.250 | 100,00% |
| Quotaholders of Pelmo87 Srl |
Nr Quotas |
% of share capital with right of vote |
|---|---|---|
| Luciano Fecondini | 2.426.670 | 71,89% |
| Andrea Bocchi | 948.930 | 28,11% |
| Total | 3.375.600 | 100,00% |
***
Medica Profile
Medica Group is operating since 1985 in the biomedical district of Mirandola (Italy). Development of innovative products for blood purification has always been company's core business. Thanks to
UNI CEI EN ISO 9001:2015 UNI CEI EN ISO 13485:2016
Capitale sociale € 4.223.250,00 i.v. – Registro Ditte/REA n° 229672 – Registro Imprese di Modena n° 01604300366 Iscrizione Registro Nazionale Produttori A.E.E. n. IT08020000003645 Partita IVA e Codice Fiscale 01604300366 – Identification Number IT 01604300366
MEDICA S.p.A. Via Degli Artigiani, 7 41036 MEDOLLA MODENA - ITALY
Tel. 0535 51159 Fax 0535 52605 e-mail: [email protected] home page: www.medica.it
International: Tel. +39 0535 51159 Fax +39 0535 52605
the activity of two extremely dynamic R&D groups (medical equipment, membranes and disposable), the Group competes successfully in several markets, namely:
- Medical (dialysis, CRRT, ECCO2, Apheresis, DFPP, CHF, HIPEC, pre-transplant organ perfusion, bioregenerative medicine, gastroenterology, urodynamics, oxygen humidification).
- Microbiological purification of water
- Industrial automation for the biomedical sector.
R&D focus has been integrated over the years with a highly automated production systems in five different facilities, four in Italy and one in Tunisia, and two commercial entities (in US and in China).
The key success factors of the Group are:
- extrusion of hollow fiber membranes for hemofiltration, plasmapheresis, cascade filtration, oxygen humidification, ultrafiltration and microfiltration of water
- vertical integration, proved by the ability to manage not only the design and development of medical disposables and equipment, and the development of the automation technologies required for their production as well.
- International recognition with significant share of export (69% of revenues in 2020), with sales in over 60 countries.
Medica group closed the consolidated financial statement for the year 2020 with revenues of 44.1 million euros (34.7 million euros in 2019), EBITDA of 9.5 million euros (7.7 million euros in 2019), EBIT of 5.6 million euros (3.6 million euros in 2019) and net profit of 3.8 million euros (2.8 million euros in 2019). In the first 6 months of 2021, Medica realized revenues of 20.3 million euros and an EBITDA of 4.2 million euros.
For information: Investor Relations Medica Giovanni Plasmati (+39) 0535 51159 [email protected]
Euronext Growth Advisor CFO SIM S.p.A. (+39) 02 303431 [email protected]